Innate and adaptive immunity in inflammatory bowel disease A Geremia, P Biancheri, P Allan, GR Corazza, A Di Sabatino Autoimmunity reviews 13 (1), 3-10, 2014 | 1041 | 2014 |
IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease A Geremia, CV Arancibia-Cárcamo, MPP Fleming, N Rust, B Singh, ... The Journal of experimental medicine 208 (6), 1127, 2011 | 738 | 2011 |
Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells LJ Walker, YH Kang, MO Smith, H Tharmalingham, N Ramamurthy, ... Blood, The Journal of the American Society of Hematology 119 (2), 422-433, 2012 | 292 | 2012 |
Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study L Biancone, A Orlando, A Kohn, E Colombo, R Sostegni, E Angelucci, ... Gut 55 (2), 228-233, 2006 | 181 | 2006 |
Innate lymphoid cells in intestinal inflammation A Geremia, CV Arancibia-Cárcamo Frontiers in immunology 8, 1296, 2017 | 178 | 2017 |
IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies M Friedrich, M Pohin, MA Jackson, I Korsunsky, SJ Bullers, ... Nature Medicine 27 (11), 1970-1981, 2021 | 162 | 2021 |
Confirmation of the role of ATG16l1 as a Crohn's disease susceptibility gene FJR Cummings, R Cooney, S Pathan, CA Anderson, JC Barrett, J Beckly, ... Inflammatory bowel diseases 13 (8), 941-946, 2007 | 159 | 2007 |
The IL-23/IL-17 pathway in inflammatory bowel disease A Geremia, DP Jewell Expert review of gastroenterology & hepatology 6 (2), 223-237, 2012 | 145 | 2012 |
Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype FJR Cummings, T Ahmad, A Geremia, J Beckly, R Cooney, L Hancock, ... Inflammatory bowel diseases 13 (9), 1063-1068, 2007 | 127 | 2007 |
CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells A Kurioka, C Cosgrove, Y Simoni, B Van Wilgenburg, A Geremia, ... Frontiers in immunology 9, 486, 2018 | 122 | 2018 |
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study A Orlando, E Colombo, A Kohn, L Biancone, F Rizzello, A Viscido, ... Digestive and liver disease 37 (8), 577-583, 2005 | 101 | 2005 |
The genetics of NOD‐like receptors in Crohn's disease JRF Cummings, RM Cooney, G Clarke, J Beckly, A Geremia, S Pathan, ... Tissue antigens 76 (1), 48-56, 2010 | 87 | 2010 |
NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease T Schwerd, RV Bryant, S Pandey, M Capitani, L Meran, JB Cazier, J Jung, ... Mucosal immunology 11 (2), 562-574, 2018 | 83 | 2018 |
Local injection of infliximab in the postoperative recurrence of Crohn's disease L Biancone, M Cretella, C Tosti, G Palmieri, C Petruzziello, A Geremia, ... Gastrointestinal endoscopy 63 (3), 486-492, 2006 | 74 | 2006 |
Clinical and molecular characteristics of isolated colonic Crohn's disease L Hancock, J Beckly, A Geremia, R Cooney, F Cummings, S Pathan, ... Inflammatory bowel diseases 14 (12), 1667-1677, 2008 | 58 | 2008 |
Rofecoxib and early relapse of inflammatory bowel disease: an open‐label trial L Biancone, C Tosti, A Geremia, D Fina, C Petruzziello, S Emerenziani, ... Alimentary pharmacology & therapeutics 19 (7), 755-764, 2004 | 57 | 2004 |
Th1 and innate lymphoid cells accumulate in primary sclerosing cholangitis-associated inflammatory bowel disease A Gwela, P Siddhanathi, RW Chapman, S Travis, F Powrie, ... Journal of Crohn's and Colitis 11 (9), 1124-1134, 2017 | 53 | 2017 |
Technetium-99m–HMPAO Labeled Leukocyte Single Photon Emission Computerized Tomography (SPECT) for Assessing Crohn's Disease Extent and Intestinal Infiltration L Biancone, O Schillaci, F Capoccetti, RM Bozzi, D Fina, C Petruzziello, ... Official journal of the American College of Gastroenterology| ACG 100 (2 …, 2005 | 42 | 2005 |
Extensive weight loss reduces glycan age by altering IgG N-glycosylation VL Greto, A Cvetko, T Štambuk, NJ Dempster, D Kifer, H Deriš, A Cindrić, ... International Journal of Obesity 45 (7), 1521-1531, 2021 | 41 | 2021 |
Maintenance treatment of Crohn's disease L Biancone, C Tosti, D Fina, M Fantini, F De Nigris, A Geremia, F Pallone Alimentary pharmacology & therapeutics 17, 31-37, 2003 | 38 | 2003 |